Supplement Contaminated With Diabetes Drug Draws FDA Health Risk Alert
This article was originally published in The Tan Sheet
Executive Summary
FDA is warning consumers not to take Liqiang 4 Chinese supplement capsules due to their contamination with the diabetes medication glyburide (Pfizer's Glynase)